Telomere maintenance is regarded as a key mechanism in overcoming cellular senescence in tumor cells and in most cases is achieved by the activation of telomerase. However there is at least one alternative mechanism of telomere lengthening (ALT) which is characterized by heterogeneous and elongated telomeres in the absence of telomerase activity (TA). We evaluated the prevalence of TA, gene expression of telomerase subunits and ALT in relation to telomere morphology and function in matrix producing bone tumors and in osteosarcoma cell lines and present evidence of a direct association of ALT with telomere dysfunction and chromosomal instability. Telomere¯uorescence in situ hybridization (T-FISH) in ALT cells revealed elongated and shortened telomeres, partly in unusual con®gurations and loci, dicentric marker chromosomes and signal-free chromosome ends. Free ends give rise to end-to-end associations and may induce breakage-fusion-bridge cycles resulting in an increased number of complex chromosomal rearrangements, as detected by multiplex-FISH (M-FISH). We propose that ALT cannot be seen as an equivalent to telomerase activity in telomere maintenance. Its association with telomere dysfunction and chromosomal instability may have major implications for tumor progression. Oncogene (2001) 20, 3835 ± 3844.
Introduction
Telomeres shorten with each round of cell division (Olovnikov, 1971; Watson, 1972) . Telomere maintenance is regarded as a key mechanism in overcoming cellular senescence through immortalization in tumor cells (Wright et al., 1989; Counter et al., 1992) and in most cases this is achieved by the activation of telomerase (Greider and Blackburn, 1987; Counter et al., 1998) . Earlier investigations revealed telomerase activity (TA) in 90% of human tumors, but not in normal tissues (Kim et al., 1994; Shay and Bacchetti, 1997) .
However, the speci®c association of telomerase with cancer progression is being challenged. The frequency and biologic importance of TA seem to be subjected to tumor-type dependent variation (Wynford-Thomas, 1999) . Stem cells (Harle and Boukamp, 1996) , stimulated lymphocytes (Broccoli et al., 1995; Hiyama et al., 1995; Counter et al., 1995) and dierent highly proliferative tissues (Hiyama et al., 1996; Takubo et al., 1997; Bryan et al., 1997) exhibit TA. Moreover, an alternative mechanism of telomere lengthening (ALT) exists in a subset of human tumors and immortalized cell lines. ALT is characterized by the presence of elongated and heterogeneous telomeres in the absence of TA and is supposed, though not yet elucidated, to elongate telomeres through recombination-based interchromosomal exchanges of sequential material (Bryan et al., 1995; Biessmann and Mason, 1997; Shay and Bacchetti, 1997; Bryan et al., 1997) .
Our purpose was to evaluate the prevalence of TA and ALT in matrix producing bone tumors in regard to telomere morphology and function. We ®rst laid emphasis on the analysis of the frequency of TA in osteo-and chondrosarcomas, benign lesions with various histology, and osteosarcoma cell lines by the telomere repeat ampli®cation protocol (TRAP). Gene expression of the enzyme's catalytic subunit hTERT (Meyerson et al., 1997; Takakura et al., 1998; Ramakrishnan et al., 1998) and its endogenous RNA template hTR (Avilion et al., 1996; Ito et al., 1998; Sumida et al., 1999) was performed by quantitative real-time RT ± PCR. Secondly, we detected ALT in primary osteosarcomas and osteosarcoma cell lines by telomere length analysis using Southern blotting. Analysis of telomere morphology and function was performed by telomere PNA-¯uorescence in situ hybridization (T-FISH). Finally we investigated the occurrence of molecular cytogenetic aberrations characteristic for either TA or ALT by comparative genomic hybridization (CGH) in osteosarcomas and osteosarcoma cell lines and by 24-color multiplex FISH (M-FISH) in osteosarcoma cell lines. As a guardian of genome integrity, TP53 gene status in the osteosarcoma cell lines was analysed.
Results

Frequency of TA in matrix producing bone tumors
Sixty-eight bone tumors were assayed for TA by the TRAP assay (Table 1) . 15/29 osteosarcomas (52%) compared to 16/23 chondrosarcomas (70%) showed TA. 6/16 histologically dierent benign lesions (38%), all of chondrogenic origin, presented minimal TA. TA levels were signi®cantly lower than in any of the examined malignant tumors. When examining the corresponding histological slides, bone marrow cells and in®ltration of lymphocytes in some regions of these lesions were found. Contamination with these cells in the corresponding samples could explain our ®ndings of minimal TA (Counter et al., 1995; Harle and Boukamp, 1996) .
15/68 primary tumors (eight osteosarcomas, seven chondrosarcomas) were assayed for telomerase core component (hTERT, hTR) gene expression by quantitative real-time RT ± PCR (Table 2) . 8/8 tumors with TA (100%) were positive for hTERT gene expression and 7/7 tumors lacking TA (100%) had no detectable hTERT expression. All tumors revealed hTR expression with a tendency to higher expression in telomerase positive tumors, consistent with the literature (Avilion et al., 1996; Ito et al., 1998) .
Cell lines MNNG, HOS, OST and SJSA-1 displayed high TA with varying, but signi®cantly higher levels of hTERT and hTR gene expression when compared to Saos-2, which exhibited low TA and hTERT/hTR gene expression (Table 3 ). The osteosarcoma cell lines U2-OS and ZK-58 had no detectable TA in the TRAP assay and no hTERT expression. ZK-58 presented marginal hTR expression and U2-OS had no detectable hTR expression. Neuroblastoma cell lines Lan-5 and SK-PN-DW, used as positive controls in T-FISH and telomere length analysis, showed high levels of TA. To exclude false negative results, protein extracts of telomerase positive tumors were mixed with protein extracts of telomerase negative tumors at dierent dilutions. No inhibition of the PCR reactions of the TRAP assay was detected.
ALT, TA and telomere morphology
The 4/7 cell lines with high TA (HOS, MNNG, OST, SJSA-1) had short telomeres, with a mean length of 3.5 kb (Figure 1 ). Cell lines U2-OS and ZK-58 displayed no TA and no hTERT expression. Telomere length analysis of these cell lines by Southern blotting revealed a hybridization signal smear stretching from 52 ± 23 kb with the strongest hybridization signal present at 23 kb, thus representing the ALT phenotype (Bryan et al., 1997) . Saos-2 exhibited an intermediate ALT type with low TA, marginal hTERT and hTR expression, but elongated and heterogeneous telomeres (strongest hybridization signal at 23 kb).
To exclude that ALT is a cell culture artifact, DNA of two primary high grade osteoblastic osteosarcomas obtained from tumor biopsies without any pretreatment was included for telomere length analysis ( Figure  1 ). One tumor without TA and without hTERT expression revealed elongated and heterogeneous telomeres with a mean length of 23 kb, representing the ALT phenotype. The other tumor, with intermediate TA and high hTERT expression, had telomeres with a mean length of 4 kb.
Fluorescence in situ hybridization with a telomere specific PNA-probe (T-FISH) Twenty metaphases each of neuroblastoma cell line Lan-5 and osteosarcoma cell line OST (both with high TA), ALT cell lines U2-OS and ZK-58, intermediate type cell line Saos-2 and a normal human lymphocyte culture were examined. Aberrations present in at least 50% (10 metaphases) are described. Chromosomes of Lan-5, OST or the human normal lymphocyte culture essentially showed four¯uorescent hybridization signals at telomeric positions of similar¯uorescent intensity (Figure 2a ). In Saos-2, U2-OS and ZK-58, uorescence intensity diered greatly in chromosomes of the same metaphase and between chromosome ends. Hybridization spots with a higher and a lower intensity than in Lan-5, OST and the lymphocyte culture were found (Figure 2b) .
Large, dicentric marker chromosomes indicating end-to-end fusion were present. Telomeric repeats were found at unusual loci and con®gurations. Some chromosomes had no detectable telomeric repeats at one or both ends (signal-free ends), others displayed (Figure 2c ± e). Among chromosomes with aberrant telomere morphology, chromosomes with a`normal' telomeric phenotype were found ruling out the possibility of failed or unspeci®c hybridization (Figure 2b ). All slides were hybridized in the same assay and the procedure was performed twice with consistent results.
Comparative genomic hybridization (CGH)
The total number of molecular cytogenetic aberrations in the 24 analysed osteosarcomas ranged from three up to 35 aberrations with a mean total number of aberrations of 19+9. The seven osteosarcoma cell lines analysed revealed a mean total number of 29+7 aberrations ranging from 18 ± 33 aberrations per cell line. However, number and distribution of gains and losses of genetic material was heterogeneous and no loci were shared by all tumors and/or cell lines, or by tumors grouped according to their telomerase status. Emphasis was laid on the analysis of chromosomal regions which are related to the regulation of TA. There is evidence for a cellular telomerase repressor at chromosome 3p Shay, 1999) . The hTERT gene was recently mapped to chromosome 5p15.33 by¯uorescence in situ hybridization (Bryce et al., 2000) . Tumors were grouped into 13 tumors with and 11 tumors without TA. The Chi-square test and Fisher's Exact test for the parameters of gains/ ampli®cations and losses on chromosome 3p and 5p, respectively, revealed no dierences between both groups.
24-color multiplex fluorescence in situ hybridization (M-FISH)
Metaphases of three osteosarcoma cell lines (ZK-58 n=10, Saos-2 n=5, MNNG n=3) were analysed for structural (=rearrangements) and numerical (=aneu-ploidy) chromosomal aberrations. In the osteosarcoma cell line Saos-2 with a modal number of 52 chromosomes, 37 chromosomes (71.2%) were aected by structural aberrations, whereby a high rate of complex rearrangements composed of 3 ± 5 dierent chromosomes was found (12/37) (Figures 3 and 4b) . Very similar results were achieved by M-FISH analysis in the cell line ZK-58. Structural abnormalities were detected in 69.8% (37/53) of the chromosomes, whereby 10 chromosomes showed complex rearrangements composed of 3 ± 5 dierent chromosomal segments ( Figure 3 ). In contrast, in the osteosarcoma cell line MNNG, M-FISH detected structural aberrations only in 29.9% (18/60) of the chromosomes, whereby three chromosomes consisted of three dierent chromosomal segments (Figures 3 and 4a) . Additionally, M-FISH identi®ed a trisomy for chromosomes 1, 2, 5 and 22. When comparing ZK-58 (no TA, elongated telomeres) and Saos-2 (low TA, elongated telomeres) with MNNG (high TA, short telomeres) using the Wilcoxon test the proportion of complex rearranged chromosomes (with 3 ± 6 chromosomes involved; Figure 4c ,d) as well as the overall number of rearrangements was signi®cantly higher in ZK-58 and Saos-2 (both P=0.009). In contrast the number of trisomies was signi®cantly higher in MNNG (P=0.0001).
TP53 status
Osteosarcoma cell lines OST, SJSA-1 and ZK-58 harbored no point mutations in the coding region of the TP53 gene by sequencing using the GeneChip TP53 Assay (Table 3) .
Discussion
Approximately 40% of the malignant bone tumors included in the study displayed no TA, consistent with earlier investigations (Aue et al., 1998) . When the malignant tumors were grouped according to their histologic subtype there were dierences in the frequency of TA: whereas only half of the osteosarcoma tumor samples were positive for TA, 70% of the chondrosarcomas displayed TA. Remarkably, the histologic tumor grade of the osteosarcomas was dierent to that of the chondrosarcomas: almost all osteosarcomas included in the study were high grade, highly cellular tumors. In contrast, the collective of 23 chondrosarcomas comprised only four high grade, highly cellular chondrosarcomas, while six were low grade and 13 were intermediate grade, matrix-rich tumors with low to moderate cellularity. All high grade chondrosarcomas were positive for TA. The failure to detect TA in some of the low and intermediate grade chondrosarcomas may simply be due to low cellularity; however, this reason cannot be used to explain the lack of hTERT gene expression in highly cellular, TA negative osteosarcomas. In addition to hTERT, hTR also appeared to be related to TA. With the exception of U2-OS, all tumors and cell lines did express hTR with a tendency towards higher expression levels in telomerase-positive tumor cells. These data support the ®nding that upregulation of hTR is necessary for TA (Mitchell et al., 1999) . Moreover, because hTR expression was found in TA negative osteosarcoma cell lines and primary tumors, the lack of telomerase activity in these cells cannot be explained by an abrogation of hTR.
The equal frequency of high grade osteosarcomas with and lacking TA, together with the ®nding of ALT in the osteosarcoma cell lines U2-OS and ZK-58 and in primary tumors, suggest that TA is not mandatory for tumor progression in this entity.
As expected, in telomere length analysis, the TA positive cell lines MNNG, HOS, OST and SJSA-1 exhibited short telomeres of homogeneous length consistent with most malignant immortalized cells examined to date (Wright et al., 1996) . Semiquantitative analysis of telomere morphology of OST by T-FISH re¯ected these ®ndings by showing four uorescent spots of similar intensity at each telomeric position. A similar morphology was also found in the telomerase positive neuroblastoma cell line Lan-5 and a normal human lymphocyte culture which were included into this study as controls.
In contrast, osteosarcoma cell line Saos-2 proved to have low telomerase activity and elongated telomeres typical for the ALT phenotype. It is possible that the low telomerase activity found in Saos-2 is not sucient to prevent telomere shortening which in turn could give rise to ALT. Therefore, we referred Saos-2 to be an ALT cell line of intermediate type. Perrem et al. (1999) demonstrated that the ALT telomere phenotype was abrogated in cell hybrids between ALT and telomerasepositive cells, implying that co-existence of ALT and telomerase activity is rather unlikely. However, the nature of ALT remains unclear and dierent mechanisms or conditions can be used to describe the same phenomenon.
T-FISH¯uorescence intensity corresponds directly to telomere length (Lansdorp et al., 1996) . ALT cell lines U2-OS and ZK-58 as well as Saos-2 revealed intracellular and inter-chromosomal variations in telomere morphology, implying that the heterogeneity of telomere length found by Southern blotting TRF analysis is not simply an intercellular phenomenon due to a mixed population composed of cells with long telomeres and cells with short telomeres. The long and hyper-variable telomeres found in the ALT cell lines are reminiscent of telomerase-null survivor cells in yeast which maintain their telomeres through nonreciprocal recombination (Kass-Eisler and Greider, 2000) . Furthermore, the ALT cell lines we analysed presented not only intracellular polymorphism in telomere length but also a spectrum of unusual chromosomal loci and con®gurations of telomeric repeats with the occurrence of long, dicentric marker chromosomes.
Telomeres are important for chromosomal stability (Counter et al., 1992; Autexier and Greider, 1996) . A peak of dicentric chromosomes resulting mostly from telomeric associations occurs in SV40 transformed ®broblasts prior to crisis when telomere shortening reaches a critical point (Ducray et al., 1999) . Activated telomerase homogenizes telomeres in a dynamic balance between elongation and shortening towards a stabilized length which in turn promotes chromosomal stability. Therefore, we suggest that ALT cells do not expand their replicative potential under telomerestabilizing conditions. The occurrence of elongated and shortened telomeres and signal-free chromosome ends could give rise to chromosomal end-to-end associations and breakage-fusion-bridge cycles (McClintock, 1941; Autexier and Greider, 1996; Bouer et al., 1996) resulting in an increased number of complex non-reciprocal chromosomal rearrangements in TA negative cells. Evidence to support this hypothesis is provided by our preliminary M-FISH data. Furthermore, we are in the process of con®rming these results with additional telomerase-negative tumor cell lines exhibiting an ALT phenotype. A function of telomerase in`healing' broken chromosome ends, as proposed by Melek and Shippen (1996) , would provide another aspect why ALT cells have features of chromosomal instability.
Furthermore, increasing data suggests that rescue of telomeric function is not only determined by net lengthening of telomeres. Zhu et al. (1996) proposed a requirement for capping of telomeres by telomerase, another function that might be abrogated in ALT cells.
Although ALT appears only in a subset of tumors, particularly of mesenchymal origin, its direct association with telomeric dysfunction may have important implications for the valuation of chromosomal instability in tumor progression. ALT does not seem to be an equivalent to telomerase in telomere maintenance; the requirement of telomere stabilization in tumor progression might be dependent on preceding mutations during tumorigenesis. Further studies are needed to analyse if tumor cells that are originally TA positive may become TA negative ALT cells when treated with the emerging group of small molecule drugs able to inhibit telomerase activity.
Materials and methods
Materials
Tumor specimens were derived from snap-frozen material of primary tumor biopsies and surgical resections and stored at 7808C until use. Clinicopathological data comprises diagnosis, sex, age at diagnosis and tumor cell content in the obtained specimens. The patient's mean age at diagnosis was 21+13 years for the osteosarcomas, 54+13 years for the chondrosarcomas and 32+18 years for the benign lesions. Tumor cell content in relation to the whole tissue area (matrix) evaluated by histologic study ranged from 5 ± 100% in malignant tumors and 5 ± 80% in the benign lesions.
Furthermore, osteosarcoma cell lines HOS, MNNG, OST, SJSA-1, Saos-2, U-2 OS and ZK-58, and the neuroblastoma cell line Lan-5 were included in the study.
Protein preparation and telomerase assay
Extractions of cellular proteins of the tumor specimens were prepared as previously described . Osteosarcoma cell lines were washed with cold Phosphate Buered Saline (PBS) prior to extraction. The protein concentrations were measured by use of the Coomassie Protein Assay Reagent (Bio Rad, USA) on an ELISA Reader and adjusted to about 2 mg/ml.
For in vitro detection of TA, a modi®ed version of the telomeric repeat ampli®cation protocol (TRAP) assay including an internal PCR-ampli®cation control from a commercially available kit (TRAPeze telomerase detection kit, Oncor, Gaithersburg, MD, USA) was used, resulting in a 36-bp product which was co-ampli®ed with telomerase-elongated products in a competitive manner (Poremba et al., 1999) . Each analysis comprised a telomerase positive control cell line included in the kit, a heat-inactivated control (telomer-ase-positive control incubated at 858C for 10 min prior to reaction) and a negative control (CHAPS lysis buer instead of sample protein). Electrophoresis and semiquantitative analysis of chromatogram peaks generated from photodetector signals were performed as described on an automated laser-¯uorescence sequencer (ALFexpress, Pharmacia, Freiburg, Germany). TRAP data was analysed in blind-trial fashion. For each tumor sample, the TRAP procedure was done twice and levels of telomerase activity proved to be consistent in all the samples included in this study. To rule out the possibility of telomerase and Taqpolymerase inhibiting factors, mixed tissue samples that contained telomerase-negative and positive extracts were prepared. Interpretation of proportions distinguished between absent TA, low (530% of positive control), intermediate (30 ± 70% of positive control) and high TA (470% of positive control) as previously described .
Assessment of tissue sample preservation by RT ± PCR of RNA content
In order to minimize the probability of false-negative results, with a lack of or low TA due to tissue degradation and necrosis, RNA derived from frozen sections was ampli®ed by reverse-transcriptase PCR (RT ± PCR) for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an indirect marker of tissue integrity. Brie¯y, a 297-bp fragment of the human GAPDH gene was ampli®ed with primers 5'-CACCCATGG-CAAATTCCATGGC-3' and 5'-GCATTGCTGATGAT-CTTGAGGCT-3', correponding to GenBank positions 213 ± 234 and 509 ± 487, respectively (GenBank Accession Number M33197). For a small subset of tumors, no RNA was available. For those lesions, viability of the TRAP assay was veri®ed by tumor cell count on hematoxylin-eosin stained histologic slides.
Quantitative real-time RT ± PCR for expression of hTERT and hTR
Total RNA was isolated from fresh-frozen tissue using the TRISOLV system (Biozol, Eching, Germany) in accordance with the manufacturer's protocol. RNA was treated with DNAse (Eurogentec, Seraing, Belgium) and puri®ed by repeating the TRISOLV extraction protocol. cDNA was synthesized from approximately 2 mg of RNA using the FirstStrand Synthesis Kit (AmershamPharmacia, Freiburg, Germany) with dT 18 primers. Relative concentrations of cDNA samples were evaluated by quantitative RT ± PCR of GAPDH performed on the LightCycler (Roche Diagnostics, Mannheim, Germany) followed by analysis of the gene expression of the telomerase catalytic subunit hTERT and the RNA component hTR. For ampli®cation of the cDNA, 5 ml aliquots of reverse-transcribed cDNA were subjected to PCR in 20 ml containing a ®nal concentration of 2 ± 3 mM MgCl 2 , 0.5 mM of each primer, and 2 ml of ready-to-use LightCycler DNA Master SYBRGreen I (106, containing TaqDNA polymerase, reaction buer, dNTP mix with dUTP instead of dTTP, SYBRGreen I dye, and 10 mM MgCl 2 ). For hot-start PCR, 0.16 ml/sample of TaqStart Antibody (Clontech, Heidelberg, Germany) was added to the ampli®cation mixture prior to the addition of primers and template cDNA. hTERT mRNA was ampli®ed using the primers hTERT-1 (5'-CGGAAGAGTGTCTGGAGCAA-3') corresponding to GenBank positions 1785 ± 1804 and hTERT-2 (5'-CATG-GACTACGTCGTGGGAG-3') corresponding to positions 1961 ± 1980 (GenBank Accession number AF018167). hTR RNA was ampli®ed using the primers hTR-1 (5'-CCTAACT-GAGAAGGGCGTAGGC-3') corresponding to GenBank positions 849 ± 870 and hTR-2 (5'-CTAGAATGAACGGTG-GAAGGCG-3') corresponding to positions 961 ± 940 (GenBank accession number AF047386). The reaction conditions were initial denaturation at 958C for 2 min followed by 35 ± 40 cycles of denaturation at 958C for 1 s, annealing at 608C for 5 s and extension at 728C for 6 ± 8 s (depending on ampli®cation length). Quantitative analysis was performed using the LightCycler Software employing a real-timē uorogenic detection system for a kinetic, rather than endpoint approach as on conventional agarose or polyacrylamide gels. The generation of quantitative data was based on the dierent PCR kinetics of samples with dierent levels of target gene expression. We employed a relative quanti®cation (Poremba et al., 2000) in which the expression levels of the tumor samples and osteosarcoma cell lines were compared to the data from the Ewing's tumor telomerase positive cell line VH-64 in a geometric dilution series (1 : 1, 1 : 2, 1 : 4, 1 : 8, 1 : 16, 1 : 32). The graph of the linear regression and calculation of the regression coecient, r, served to con®rm accuracy and reproducibility of this approach. For this approach, the identity and speci®city of the PCR product was con®rmed by melting curve analysis which is part of the LightCycler analysis program. The speci®c melting point of the PCR product was correlated with its molecular weight determined by agarose gel electrophoresis.
Evaluation of hTERT expression in the seven osteosarcoma cell lines was performed by using the LightCycler Telo-TAGGG-Kit (Roche Diagnostics, Mannheim, Germany) which comprises a one-step RT ± PCR in which relative quanti®cation is realized by normalizing hTERT gene expression on expression of PBGD (porphobilinogen deaminase). For the ampli®cation, 2-ml prediluted aliquots containing approximately 200 ng of total RNA were subjected to ®rst strand-synthesis and subsequent ampli®cation in a ®nal volume of 20 ml containing 16ready-to-use Reaction Mix, 0.1 ml reverse transcriptase, 16hTERT Detection Mix or PBGD reaction mix and a ready-to-use primer and hybridization probe mixture speci®c for either hTERT or PBGD mRNA. Probes consist of two dierent¯uorescein-labeled short oligonucleotides that hybridize to an internal sequence of the ampli®ed fragment during the annealing phase and emit a¯uorescence signal in close proximity through¯uorescence resonance energy transfer (FRET). Prediluted RNA standards for establishing a reference curve as well as a positive control RNA to ensure reliability and reproducibility were included in the kit.
DNA extraction
Genomic DNA was prepared by proteinase K digestion according to the Puregene DNA extraction protocol (Biozym, Hess. Oldendorf, Germany) followed by treatment with RNase A.
Telomere length analysis
Telomeric restriction fragment (TRF) length analysis was carried out using the Telomere Length Assay Kit (Pharmingen, San Diego, CA, USA). In brief, 5 mg of genomic DNA was digested with a HinfI/RsaI restriction enzyme mixture. Digested DNA was loaded onto 0.6% agarose gels and run at 5 V/cm for approximately 3 h. BstEII and HindIII digested l DNA supplied with the kit were used as length standards. Southern transfer blot onto a positively charged nylon membrane (Roche Diagnostics, Mannheim, Germany) was realized by alkaline vacuum blotting using the VacuGene XL blotting unit according to the manufacturer's protocol (Amersham Pharmacia). Membranes were then hybridized overnight at 558C with 5 ng/ml of an 51-mer biotinylated telomere probe (Pierce Chemical Co., USA). Stringency washes were carried out by washing membranes three times for 5 min in 26SSC/0.1% SDS at room temperature. Chemiluminescent detection was performed with Streptavidin-HRP (1 : 300) with solutions and in accordance to instructions supplied with the Telomere Length Assay kit. Exposure of an X-ray ®lm (X-omat AR, Kodak, Rochester, NY, USA) to the membrane revealed telomere lengths as smears ranging from 1.9 to more than 23.1 kilobases (kb). TRF length analysis was performed on a densitometric scan of the autoradiogram, calculating the mean TRF length for each sample by integrating the signal intensity above background over the entire TRF distribution as a function of TRF length (L=S(OD i 6L i )/S(OD i ), where OD i and L i are the signal intensity and TRF length respectively at position i on the gel image).
Telomere fluorescence in situ hybridization (T-FISH)
T-FISH analysis was carried out using the DAKO Telomere PNA FISH Kit/Cy3 (DAKO, Glostrup, Denmark). Metaphase spreads were prepared according to standard procedures and immersed in Tris-buered Saline (TBS) for 5 min prior to ®xation in 3.7% formaldehyde in TBS for 2 min, washes in TBS for 265 min and treatment with proteinase K (DAKO, Glostrup, Denmark) for 10 min. After further washes in TBS for 265 min, slides were dehydrated with a cold ethanol series and air-dried. Ten microliters of Cy3-conjugated telomere speci®c peptide nucleic acid (PNA) probe in hybridization solution containing 70% formamide was added and DNA was denatured by heat for 3 min at 808C. After hybridizing in the dark for 30 min, slides were brie¯y immersed in Rinse Solution (supplied with the kit) and then washed at 658C for 5 min in Wash Solution (supplied with the kit). After rinsing with TBS slides were counterstained with DAPI, and mounted with antifade solution (VectaShield, Vector laboratories Inc., Burlingame, CA, USA).
Separate digitized gray level images of DAPI and Cy3 uorescence were taken with a charge coupled device (CCD) camera (Cohu 6X-924) connected to a Leica DMRBE microscope. The image processing was carried out by use of Applied Image Software.
Comparative genomic hybridization (CGH)
CGH analysis, microscopy and digital image analysis was performed as previously described (Brinkschmidt et al., 1998) . Brie¯y, tumor or cell line DNA was labeled with biotin-16-dUTP (Roche Diagnostics, Mannheim, Germany) and reference DNA from a healthy male donor was labeled with digoxigenin-11-dUTP (Roche Diagnostics, Mannheim, Germany) in a standard nick reaction. For CGH, 500 ng of the tumor DNA, 500 ng of reference DNA and 30 mg of human Cot 1 DNA (Gibco) were used for hybridization on target metaphase spreads (46,XY) as described elsewhere. Posthybridization washes were carried out to a stringency of 50% formamide/26SSC at 458C and 0.16SSC at 608C. Biotinylated and digoxigenated sequences were detected simultaneously, using avidin-FITC (Roche Diagnostics, 1 : 200) and anti-digoxigenin-rhodamine (Roche Diagnostics, 1 : 40). The slides were counterstained with DAPI and mounted with antifade solution (Vectashield, Vector laboratories Inc.) Separate digitized gray level images of DAPI, FITC and rhodamine¯uorescence were taken with a CCD camera connected to a Leica DMRBE microscope. The image processing was carried out by use of Applied Image Software. Average green-red ratios were calculated for each chromosome in 5 ± 10 metaphases.
Chromosomal regions with CGH ratio pro®les surpassing the 50% CGH thresholds (upper threshold 1.25, lower threshold 0.75) were de®ned as loci with copy number gains or losses. Based on experiments with normal control DNA, these thresholds have been proved to eliminate false-positive results. As the tumor specimens and normal DNA were not sex matched, entire X and Y chromosomes were excluded.
Multiplex-fluorescence in situ hybridization (M-FISH)
Metaphase spreads from the osteosarcoma cell lines MNNG, Saos-2 and ZK-58 were prepared according to standard protocols. M-FISH was performed as described (Speicher et al., 1996; Eils et al., 1998) with minor modi®cations. Brie¯y, ®ve pools of whole chromosome painting probes (kindly provided by M Ferguson-Smith, Cambridge, UK) were ampli®ed and labeled by DOP-PCR using ®ve dierent uorochromes FITC, Cy3, Cy3.5, Cy5 and Cy5.5, respectively). About 100 ng of each chromosome painting probe was precipitated in the presence of 30 mg Cot-1 DNA, resolved in 10 ml hybridization mixture (15% dextrane sulfate, 26SSC) and hybridized for 48 h.
Microscopic evaluation was performed using a Leica DMRXA-RF8 microscope (Leica, Wetzlar, Germany) equipped with a Sensys CCD camera (Photometrics, Tucson, AZ, USA) with a Kodak KAF 1400 chip. Images for each uorochrome were aquired separately using highly speci®c ®lter sets (Chroma Technology Corp., Brattleboro, VT, USA) and processed using the Leica MCK software (Leica Microsystems Imaging Solutions Ltd., Cambridge, UK).
GeneChip p53 assay
DNA extracted from osteosarcoma cell lines OST, SJSA-1 and U2-OS was sequenced using the GeneChip p53 assay (Aymetrix, Santa Clara, CA, USA) according to the manufacturer's protocol. TP53 exons 2 ± 11 from each cell line DNA were ampli®ed as 10 separate amplicons in a decaplex PCR. Each 100-ml PCR contained PCR Buer II (Perkin Elmer), 2.5 mM MgCl 2 (Perkin Elmer), 0.2 mM of each dNTP (Sigma), 5 ml of the p53 Primer Set (Aymetrix), 10 U of AmpliTaq Gold TM (Perkin-Elmer), and 250 ng of genomic DNA. PCR was carried out on MJ Research, Inc., thermocyclers under the following reaction conditions: initial denaturation at 958C for 10 min, followed by 35 cycles of 958C for 30 s, 608C for 30 s, and 728C for 45 s, with a ®nal extension at 728C for 10 min. Forty-®ve-ml volumes of tumor or reference amplicons were subjected to fragmentation using 0.25 U of GeneChip Fragmentation Reagent (Aymetrix) at 258C for 15 min in 0.4 mM EDTA (Gibco ± BRL Life Technologies), 2.5 U of calf intestine alkaline phosphatase (Amersham-Pharmacia Biotech), and 0.5 mM Tris.acetate (pH 8.2) (Teknova) before heat inactivation at 958C for 10 min.
The fragmented tumor or reference DNAs (50 ml) were 3' end labeled with¯uorescein-N6-dideoxy-ATP. Twenty-®ve U of terminal transferase (Promega), TdTase Buer (Promega), 10 mM¯uorescein-N6-ddATP (DuPont/NEN), and the fragmented DNA were incubated at 378C for 45 min in a 100-ml reaction followed by heat inactivation at 958C for 5 min. Thē uorescein-labeled DNAs were hybridized to the GeneChip p53 probe arrays using the GeneChip Fluidics Station 400. 0.5-ml reaction volumes containing 6X SSPE (0.9 M NaCl, 0.06 M NaH 2 PO 4 , 6 mM EDTA) (Bio Whitakker), 0.05% Triton 1 X-100 (Sigma), 1 mg of acetylated BSA (Sigma), 2 nM Control Oligonucleotide F1 (Aymetrix), and the labeled DNAs were hybridized at 458C for 30 min. Each probe array was washed twice with Wash Buer A (36SSPE, 0.005% Triton 1 X-100) at 358C prior to being scanned on a HP GeneArray Scanner (Hewlett-Packard). The captured light signals were analysed using GeneChip Software.
